FYERS
Marksans Pharma321.15
+5.85 (+1.86%)

Marksans Pharma Share Price

321.15+5.85 (+1.86%)
+68.69% past 1 Year

Shareholding summary

Promoters
43.87%
FII
19.06%
DII
1.82%
MF
3.72%
Others
31.53%
Promoters
FII
DII
MF
Others
Quarterly
Yearly

Shareholding Pattern

Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025
43.87%43.87%43.87%43.87%43.87%43.87%
19.06%17.47%16.76%8.13%16.92%19.89%
1.82%1.83%1.91%1.50%1.36%1.95%
3.72%4.36%4.66%4.41%3.92%3.55%
31.53%32.47%32.80%42.09%33.93%30.74%

Bulk & block deals

Name
Microcurves Trading Private Limited
Microcurves Trading Private Limited
Unifi Capital Private Limited
Unifi Blend Fund 2
Orbimed Asia Iv Mauritius Fvci Limited
Unifi Capital Private Limited -Blended Rangoli
Uti Mutual Fund
Unifi Capital Private Limited
Unifi Bcad Fund
Societe Generale
Deal DateActionDeal ValueDeal PriceQty TradedDeal Type%Stake TradedExchange
12 Aug 2026Sell136.32 Cr₹313.4043.50 LBulk0.959851NSE
12 Aug 2026Purchase136.25 Cr₹313.2443.50 LBulk0.959851NSE
28 Jul 2025Purchase167.64 Cr₹231.5072.41 LBulk1.597946BSE
11 Jun 2025Purchase74.98 Cr₹249.9530 LBulk0.662012NSE
11 Jun 2025Sell256.78 Cr₹249.951.03 CrBulk2.267049NSE
11 Jun 2025Purchase81.17 Cr₹249.9532.48 LBlock0.716651NSE
11 Jun 2025Purchase10.35 Cr₹249.954.14 LBlock0.091378NSE
11 Jun 2025Purchase14.85 Cr₹249.955.94 LBlock0.131078NSE
11 Jun 2025Purchase14 Cr₹249.955.60 LBlock0.123576NSE
11 Jun 2025Purchase23 Cr₹249.959.20 LBlock0.203058NSE

Insider trading & SAST

Client name
Merrill Jean Saldanha
Marise Ann Saldanha
Sandra Saldanha
Schenelle Megan Saldanha
Orbimed Asia Iv Mauritius Fvci Ltd
Sandra Saldanha
Sandra Saldanha
Arvind Singh
Arvind Singh
Arvind Singh
Reported onClient categoryAction%Stake tradedHolding % post dealDeal valueDeal priceQty tradedDeal periodDeal modePost transaction holdingInsider/SASTRegulation typeSecurity type
17 Sep 2026Directors Immediate RelativeAcquisition0.0139630.010—63.27 K11 Sep 2026Gift63,273Insider Trading—Equity
17 Sep 2026Directors Immediate RelativeAcquisition0.00441300—20 K11 Sep 2026Gift20,000Insider Trading—Equity
17 Sep 2026DirectorDisposal0.0503730.020—2.28 L11 Sep 2026Gift1,02,183Insider Trading—Equity
17 Sep 2026Directors Immediate RelativeAcquisition0.0319970.030—1.45 L11 Sep 2026Gift1,45,000Insider Trading—Equity
09 Jul 2025OtherDisposal2.278.620—1.03 Cr11 Jun 2025Market3,90,50,881SAST29(2)—
06 Jun 2024PromoterAcquisition0.0139630.0789.52 L₹141.4863.28 K05 Jun 2024Market Purchase3,30,456Insider Trading—Equity Shares
04 Jun 2024PromoterAcquisition0.0103720.0668.62 L₹146.0147 K03 Jun 2024Market Purchase2,67,180Insider Trading—Equity Shares
22 Aug 2023EmployeeAcquisition0.00066203.47 L₹115.753 K14 Aug 2023 - 18 Aug 2023Market Purchase3,000Insider Trading—Equity Shares
22 Aug 2023EmployeeDisposal0.00143407.61 L₹117.066.50 K14 Aug 2023 - 18 Aug 2023Market Sale5,000Insider Trading—Equity Shares
22 Aug 2023EmployeeDisposal0.00044103.28 L₹163.922 K14 Aug 2023 - 18 Aug 2023Market Sale3,000Insider Trading—Equity Shares

Marksans Pharma Ltd Share Price Today

The Marksans Pharma Ltd share price today is ₹325. During the trading session, the Marksans Pharma Ltd share price opened at ₹322.05 and recorded an intraday high of ₹332.5 and a low of ₹318.15. Last closing price was ₹322.3. Over the past 52 weeks, the Marksans Pharma Ltd share price has ranged between ₹155 and ₹350.95. The current Marksans Pharma Ltd stock price reflects real-time market activity based on executed trades on the exchange.